Trial

Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary Tuberculosis

Study Director
Andreas Diacon
Start Date
9 / 2014
Trial Phase
Phase II
Trial Status
published
Current Enrollment
46
Target Enrollment
45
Overview